Search

Your search keyword '"Samoilova, Olga"' showing total 268 results

Search Constraints

Start Over You searched for: Author "Samoilova, Olga" Remove constraint Author: "Samoilova, Olga"
268 results on '"Samoilova, Olga"'

Search Results

2. Ibrutinib in combination with rituximab is highly effective in treatment of chronic lymphocytic leukemia patients with steroid refractory and relapsed autoimmune cytopenias

5. Cusatuzumab plus azacitidine in newly diagnosed acute myeloid leukaemia ineligible for intensive chemotherapy (CULMINATE): part one of a randomised, phase 2, dose optimisation study

7. Melflufen or pomalidomide plus dexamethasone for patients with multiple myeloma refractory to lenalidomide (OCEAN): a randomised, head-to-head, open-label, phase 3 study

8. Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study

9. The Behavior of Al0.5CoCrFeNiCuPt0.3 High-Entropy Alloy During High-Temperature Oxidation.

10. Use of laser cladding for the synthesis of coatings from high-entropy alloys reinforced with ceramic particles

11. Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial

13. ALL-329 Ph-Negative Acute Lymphoblastic Leukemia (ALL) in Adolescent and Young Adults: Long-Term Outcomes After Treatment According to the Adult Strategy RALL Protocol

14. POSTER: ALL-329 Ph-Negative Acute Lymphoblastic Leukemia (ALL) in Adolescent and Young Adults: Long-Term Outcomes After Treatment According to the Adult Strategy RALL Protocol

15. Investigation of Whispering Gallery Modes in Circular Arrays of Dielectric Spherical Particles using multisphere Mie Scattering formalism

16. Efficacy, pharmacokinetics, and safety of the biosimilar CT-P10 in comparison with rituximab in patients with previously untreated low-tumour-burden follicular lymphoma: a randomised, double-blind, parallel-group, phase 3 trial

17. PB1866: IS ALLO-HSCT IN CR1 NECESSARY FOR AML PATIENTS WITH MRD NEGATIVITY ACHIEVED AFTER THE FIRST INDUCTION COURSE? RUSSIAN PROSPECTIVE MULTICENTER RANDOMIZED TRIAL IN AML PATIENTS UNDER THE AGE OF 60

18. P396: FIFTEEN YEARS OF RUSSIAN RESEARCH IN THE TREATMENT OF ADULT PATIENTS WITH ACUTE PH-NEGATIVE LYMPHOBLASTIC LEUKEMIA ACCORDING TO THE PROTOCOLS ALL-2009 AND ALL-2016.

20. Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study

21. Systemic Exposure of Rituximab Increased by Ibrutinib: Pharmacokinetic Results and Modeling Based on the HELIOS Trial

22. Effect of Pt Addition on the Oxidation and Corrosion Resistance of Al 0.25 CoCrFeNi High-Entropy Alloy.

26. Ibrutinib in combination with rituximab is highly effective in treatment of steroid refractory autoimmune hemolytic anemia

28. Nationalism as a threat to European security

31. CLL-186 Interim Results From ASSURE: A Phase 3b Safety Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukemia

32. Interim Results From ASSURE: A Phase 3b Safety Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukemia

33. Microstructure and Wear Behavior of Al0.25CoCrFeNiSi0.6 High-Entropy Alloy Coating Deposited on Stainless Steel by Detonation Spraying.

34. Impact of ixazomib‐lenalidomide‐dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging‐markets subgroup of the TOURMALINE‐MM1 trial

37. Corrosion Resistance of Al 0.5 CoCrFeNiCu x Ag y (x = 0.25, 0.5; y = 0, 0.1) High-Entropy Alloys in 0.5M H 2 SO 4 Solution.

41. Study of the Influence of V, Mo and Co Additives on the Carbide Formation and Microhardness during Thermal Diffusion Chrome Planting of X35CrNi2-3 Steel.

42. ELEVATE-RR – first head-to-head trial of acalabrutinib versus ibrutinib in previously treated high risk chronic lymphocytic leukemia

44. Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma

45. Al 0.25 CoCrFeNiV High Entropy Alloy Coating Deposited by Laser Cladding on Stainless Steel.

46. Microstructural evolution of Al0.25CoCrFeNiCu and Al0.45CoCrFeNiSi0.45 high-entropy alloys during laser cladding.

50. Bortezomib plus melphalan and prednisone for initial treatment of multiple Myeloma

Catalog

Books, media, physical & digital resources